Angiotensin II stimulates and atrial natriuretic peptide inhibits human visceral adipocyte growth

International Journal of Obesity

Volumn 32, Issue 2, 2008, Pages 259-267

  Sarzani, R ^a   Marcucci, P ^a   Salvi, F ^a   Bordicchia, M ^a   Espinosa, E ^a   Mucci, L ^a   Lorenzetti, B ^a   Minardi, D ^a   Muzzonigro, G ^a   Dessi Fulgheri P ^a   Rappelli, A ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Adipocytes; Angiotensin II; Atrial natriuretic peptide; Human; Visceral adipose tissue

Indexed keywords

8 BROMO CYCLIC GUANOSINE MONOPHOSOHATE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BROXURIDINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; UNCLASSIFIED DRUG; VALSARTAN;

ADIPOCYTE; ADULT; AGED; APOPTOSIS; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADIPOCYTES; ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; CELL DIFFERENTIATION; CELL PROLIFERATION; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED;

EID: 39449127444     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803724     Document Type: Article

References (40)

1. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al., American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113: 898-918.
2. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Panel III criteria for the metabolic syndrome. Diabetes 2004; 53: 2087-2094.
3. Aneja A, El-Atat F, McFarlane SI, Sowers JR. Hypertension and obesity. Recent Progr Horm Res 2004; 59: 169-205.
4. Engeli S, Negrel R, Sharma AM. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 2000; 35: 1270-1277.
5. Lafontan M, Moro C, Sengenes C, Galitzky J, Crampes F, Berlan M. An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic non-esterified fatty acids levels in humans. Arterioscler Thromb Vasc Biol 2005; 25: 2032-2042.
6. Birkenfeld AL, Boschmann M, Moro C, Adams F, Heusser K, Franke G et al. Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans. J Clin Endocrinol Metab 2005; 90: 3622-3628.
7. Jones BH, Standridge MK, Moustaid N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 1997; 138: 1512-1519.
8. Darimont C, Vassaux G, Ailhaud G, Negrel R. Differentiation of preadipose cells: paracrine role of prostacyclin upon stimulation of adipose cells by angiotensin-II. Endocrinology 1994; 135: 2030-2036.
9. Crandall DL, Armellino DC, Busler DE, McHendry-Rinde B, Kral JG. Angiotensin II receptors in human preadipocytes: role in cell cycle regulation. Endocrinology 1999; 140: 154-158.
10. Saint-Marc P, Kozak LP, Ailhaud G, Darimont C, Negrel R. Angiotensin II as a trophic factor of white adipose tissue: stimulation of adipose cell formation. Endocrinology 2001; 142: 487-492.
11. Sugihara H, Yonemitsu N, Miyabara S, Toda S. Proliferation of unilocular fat cells in the primary culture. J Lipid Res 1987; 28: 1038-1045.
12. Zhang HH, Kumar S, Barnett AH, Eggo MC. Ceiling culture of mature human adipocytes: use in studies of adipocyte functions. J Endocrinol 2000; 164: 119-128.
13. Gillespie EL, White CM, Kardas M, Lindberg M, Coleman CI. The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care 2005; 28: 2261-2266.
14. Abuissa H, Jones PG, Marso SP, O'Keefe Jr JH. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 2005; 46: 821-826.
15. Matsushita K, Wu Y, Okamoto Y, Pratt RE, Dzau VJ. Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension 2006; 48: 1095-1102.
16. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 2002; 51: 1699-1707.
17. Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006; 27: 47-72.
18. Silberbach M, Roberts Jr CT. Natriuretic peptide signaling: molecular and cellular pathways to growth regulation. Cell Signal 2001; 13: 221-231.
19. Sengenes C, Zakaroff-Girard A, Moulin A, Berlan M, Bouloumie A, Lafontan M et al. Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity. Am J Physiol Regul Integr Comp Physiol 2002; 283: R257-R265.
20. Souza SC, de Vargas LM, Yamamoto MT, Lien P, Franciosa MD, Moss LG et al. Overexpression of perilipin A and B blocks the ability of tumor necrosis factor aloha to increase lipolysis in 3T3-L1 adipocytes. J Biol Chem 1998; 273: 24665-24669.
21. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005; 46: 2347-2355.
22. Schling P, Schafer T. Human adipose tissue cells keep tight control on the angiotensin II levels in their vicinity. J Biol Chem 2002; 277: 48066-48075.
23. Richards AM, McDonald D, Fitzpatrick MA, Nicholls MG, Espiner EA, Ikram H et al. Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations. J Clin Endocrinol Metab 1988; 67: 1134-1139.
24. Dessi-Fulgheri P, Sarzani R, Serenelli M, Tamburrini P, Spagnolo D, Giantomassi L et al. Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives. Hypertension 1999; 33: 658-662.
25. Gratzner HG. Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science 1982; 218: 474-475.
26. Sarzani R, Fallo F, Dessi-Fulgheri P, Pistorello M, Lanari A, Rappelli A et al. Local renin-angiotensin system in human adrenals and aldosteronomas. Hypertension 1992; 19: 702-707.
27. Crandall DL, Herzlinger HE, Saunders BD, Armellino DC, Kral JG. Distribution of angiotensin II receptors in rat and human adipocytes. J Lipid Res 1994; 35: 1378-1385.
28. Entenmann G, Hauner H. Relationship between replication and differentiation in cultured human adipocyte precursor cells. Am J Physiol 1996; 270: C1011-C1016.
29. Janke J, Schupp M, Engeli S, Gorzelniak K, Boshmann M, Sharma AM et al. Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-γ activation. J Hypertens 2006; 24: 1809-1816.
30. Sharma AM, Janke J, Gorzelniak K, Engeli S, Luft FC. Angiotensin blockade prevents type 2 diabetes by formation of fat cells. Hypertension 2002; 40: 609-611.
31. Bouzegrhane F, Thibault G. Is angiotensin II a proliferative factor of cardiac fibroblasts? Cardiovasc Res 2002; 53: 304-312.
32. Velloso LA, Folli F, Sun XJ, White MF, Saad MJ, Kahn CR. Cross-talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci USA 1996; 93: 12490-12495.
33. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004; 109: 594-600.
34. Dessi-Fulgheri P, Sarzani R, Rappelli A. Role of the natriuretic peptide system in lipogenesis/lipolysis. Nutr Metab Cardiovasc Dis 2003; 13: 244-249.
35. Sarzani R, Dessi-Fulgheri P, Paci MV, Espinosa E, Rappelli A. Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest 1996; 19: 581-585.
36. Dessi-Fulgheri P, Sarzani R, Tamburrini P, Moraca A, Espinosa E, Cola G et al. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens 1997; 15: 1695-1699.
37. Sarzani R, Dessi-Fulgheri P, Salvi F, Serenelli M, Spagnolo D, Cola G et al. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives. J Hypertens 1999; 17: 1301-1305.
38. Sarzani R, Strazzullo P, Salvi F, Iacone R, Pietrucci F, Siani A et al. Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity. Obes Res 2004; 12: 351-356.
39. Johnston CI, Hodsman PG, Kohzuki M, Casley DJ, Fabris B, Phillips PA. Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system: endogenous antagonists. Am J Med 1989; 87: 24S-28S.
40. Goossens GH, Blaak EE, Arner P, Saris WH, van Baak MA. Angiotensin II: a hormone that affects lipid metabolism in adipose tissue. Int J Obes (Lond) 2007; 31: 382-384.